Radicicol-sensitive peptide binding to the N-terminal portion of GRP94

被引:57
作者
Vogen, S
Gidalevitz, T
Biswas, C
Simen, BB
Stein, E
Gulmen, F
Argon, Y
机构
[1] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA
[2] Univ Chicago, Comm Cell Physiol, Chicago, IL 60637 USA
[3] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA
关键词
D O I
10.1074/jbc.M205323200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
GRP94 is a molecular chaperone that carries immuno-logically relevant peptides from cell to cell, transferring them to major histocompatibility proteins for presentation to T cells. Here we examine the binding of several peptides to recombinant GRP94 and study the regulation and site of peptide binding. We show that GRP94 contains a peptide-binding site in its N-terminal 355 amino acids. A number of peptides bind to this site with low on- and off-rates and with specificity that is distinct from that of another endoplasmic reticulum chaperone, BiP/GRP78. Binding to the N-terminal fragment is sufficient to account for the peptide binding activity of the entire molecule. Peptide binding is inhibited by radicicol, a known inhibitor of the chaperone activities of HSP90-family proteins. However, the peptide-binding site is distinct from the radicicol-binding pocket, because both can bind to the N-terminal fragment simultaneously. Furthermore, peptide binding does not cause the same conformational change as does binding of radicicol. When the latter binds to the N-terminal domain, it induces a conformational change in the downstream, acidic domain of GRP94, as measured by altered gel mobility and loss of an antibody epitope. These results relate the peptide-binding activity of GRP94 to its other function as a chaperone.
引用
收藏
页码:40742 / 40750
页数:9
相关论文
共 54 条
[1]   CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin [J].
Basu, S ;
Binder, RJ ;
Ramalingam, T ;
Srivastava, PK .
IMMUNITY, 2001, 14 (03) :303-313
[2]   Cutting edge: CD91-independent cross-presentation of GRP94(gp96)-associated peptides [J].
Berwin, B ;
Hart, JP ;
Pizzo, SV ;
Nicchitta, CV .
JOURNAL OF IMMUNOLOGY, 2002, 168 (09) :4282-4286
[3]   HEAT-SHOCK PROTEIN VACCINES AGAINST CANCER [J].
BLACHERE, NE ;
UDONO, H ;
JANETZKI, S ;
LI, ZH ;
HEIKE, M ;
SRIVASTAVA, PK .
JOURNAL OF IMMUNOTHERAPY, 1993, 14 (04) :352-356
[4]   Heat shock protein-based cancer vaccines and related thoughts on immunogenicity of human tumors [J].
Blachere, NE ;
Srivastava, PK .
SEMINARS IN CANCER BIOLOGY, 1995, 6 (06) :349-355
[5]   Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity [J].
Blachere, NE ;
Li, ZH ;
Chandawarkar, RY ;
Suto, R ;
Jaikaria, NS ;
Basu, S ;
Udono, H ;
Srivastava, PK .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (08) :1315-1322
[6]  
BLONDELGUINDI S, 1993, J BIOL CHEM, V268, P12730
[7]   AFFINITY PANNING OF A LIBRARY OF PEPTIDES DISPLAYED ON BACTERIOPHAGES REVEALS THE BINDING-SPECIFICITY OF BIP [J].
BLONDELGUINDI, S ;
CWIRLA, SE ;
DOWER, WJ ;
LIPSHUTZ, RJ ;
SPRANG, SR ;
SAMBROOK, JF ;
GETHING, MJH .
CELL, 1993, 75 (04) :717-728
[8]  
Chen SY, 1998, CELL STRESS CHAPERON, V3, P118, DOI 10.1379/1466-1268(1998)003<0118:DIOPAT>2.3.CO
[9]  
2
[10]  
Davis DP, 1999, J IMMUNOL, V163, P3842